The invention relates to a therapeutic product comprising an oestrogen and a pure antioestrogen for simultaneous, sequential or separate use in selective oestrogen therapy of perimenopausal or postmenopausal conditions; to a process for the manufacture of said product and to a pharmaceutical composition containing said product. The invention also relates to a pharmaceutical composition comprising an oestrogen and a pure antioestrogen and to a process for the manufacture of said composition.
本发明涉及一种由
雌激素和纯抗
雌激素组成的治疗产品,可同时、连续或单独用于围绝经期或绝经后病症的选择性
雌激素治疗;涉及制造所述产品的工艺和含有所述产品的药物组合物。本发明还涉及一种包含
雌激素和纯抗
雌激素的药物组合物,以及制造所述组合物的工艺。